UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Blastocystis species

Authors
Karin Leder, MBBS, FRACP, PhD, MPH, DTMH
Peter F Weller, MD, FACP
Section Editor
Edward T Ryan, MD, DTMH
Deputy Editor
Elinor L Baron, MD, DTMH

INTRODUCTION

Blastocystis species (previously referred to as Blastocystis hominis) are anaerobic protozoan parasites found in the human gastrointestinal tract [1]. The organism was initially discovered in 1911 and for many years was considered to be a harmless yeast. Studies in the 1970s demonstrated that Blastocystis spp are protozoans [2,3]. Blastocystis spp are among the most common organisms to be detected in stool specimens, but there is considerable controversy regarding whether they represent a commensal organism or a true pathogen. (See "Nonpathogenic enteric protozoa".)

EPIDEMIOLOGY

Blastocystis spp have been observed worldwide [4]. The organism resides in the colon and cecum of children and adults. The mode of transmission is not fully understood; fecal-oral transmission has been postulated [5]. Some authors have suggested that contaminated water may also be a source of infection [6-9]. Blastocystis spp have also been found in animals including pigs, monkeys, rodents, and poultry. There seems to be poor host specificity; transmission occurs from human to human and between humans and animals [10]. Blastocystis infections are more common among individuals with occupational exposure to animals, supporting the potential for zoonotic transmission.

The prevalence of Blastocystis spp varies between countries and between communities [1]. In general, the estimated prevalence of Blastocystis spp is higher in developing countries than developed countries (30 to 50 percent versus 5 to 10 percent, respectively). This may be related to poor hygiene, animal exposure, and consumption of contaminated food or water [1]. In one study from Senegal, 100 percent of 93 fecal samples were positive for Blastocystis spp [11]. In a study from Canada, 8 percent of stool samples submitted to a reference laboratory were positive for Blastocystis spp; when Blastocystis was the sole organism identified, 76 percent of subjects continued to harbor the parasite two months after initial detection [12].

Blastocystis spp are also commonly found in the stool of returned travelers from developing countries [6,13-15]. In one study of nearly 2000 stool specimens from travelers and expatriates in Nepal, the prevalence of Blastocystis spp was 30 percent [16]. (See "Travelers' diarrhea: Microbiology, epidemiology, and prevention" and "Evaluation of fever in the returning traveler".)

MICROBIOLOGY

Blastocystis spp demonstrate marked morphologic variability and measure between 5 and 40 mcm (picture 1). The organism lacks a cell wall but contains mitochondria, Golgi apparatus, and smooth and rough endoplasmic reticula typical of protozoa [17]. It reproduces asexually, usually by binary fission. It grows only under anaerobic conditions in culture, and it is highly susceptible to changes in temperature and in environmental tonicity.

              

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Thu Jun 30 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Tan KS. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 2008; 21:639.
  2. Zierdt CH, Rude WS, Bull BS. Protozoan characteristics of Blastocystis hominis. Am J Clin Pathol 1967; 48:495.
  3. Zierdt CH. Studies of Blastocystis hominis. J Protozool 1973; 20:114.
  4. Stenzel DJ, Boreham PF. Blastocystis hominis revisited. Clin Microbiol Rev 1996; 9:563.
  5. Blastocystis hominis: commensal or pathogen? Lancet 1991; 337:521.
  6. Kain KC, Noble MA, Freeman HJ, Barteluk RL. Epidemiology and clinical features associated with Blastocystis hominis infection. Diagn Microbiol Infect Dis 1987; 8:235.
  7. Nimri LF. Evidence of an epidemic of Blastocystis hominis infections in preschool children in northern Jordan. J Clin Microbiol 1993; 31:2706.
  8. Nimri L, Batchoun R. Intestinal colonization of symptomatic and asymptomatic schoolchildren with Blastocystis hominis. J Clin Microbiol 1994; 32:2865.
  9. Leelayoova S, Rangsin R, Taamasri P, et al. Evidence of waterborne transmission of Blastocystis hominis. Am J Trop Med Hyg 2004; 70:658.
  10. Parkar U, Traub RJ, Kumar S, et al. Direct characterization of Blastocystis from faeces by PCR and evidence of zoonotic potential. Parasitology 2007; 134:359.
  11. El Safadi D, Gaayeb L, Meloni D, et al. Children of Senegal River Basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis 2014; 14:164.
  12. Senay H, MacPherson D. Blastocystis hominis: epidemiology and natural history. J Infect Dis 1990; 162:987.
  13. Sheehan DJ, Raucher BG, McKitrick JC. Association of Blastocystis hominis with signs and symptoms of human disease. J Clin Microbiol 1986; 24:548.
  14. Doyle PW, Helgason MM, Mathias RG, Proctor EM. Epidemiology and pathogenicity of Blastocystis hominis. J Clin Microbiol 1990; 28:116.
  15. Jelinek T, Peyerl G, Löscher T, et al. The role of Blastocystis hominis as a possible intestinal pathogen in travellers. J Infect 1997; 35:63.
  16. Shlim DR, Hoge CW, Rajah R, et al. Is Blastocystis hominis a cause of diarrhea in travelers? A prospective controlled study in Nepal. Clin Infect Dis 1995; 21:97.
  17. Miller RA, Minshew BH. Blastocystis hominis: an organism in search of a disease. Rev Infect Dis 1988; 10:930.
  18. Zaman V, Howe J, Ng M. Variation in the cyst morphology of Blastocystis hominis. Parasitol Res 1997; 83:306.
  19. Moe KT, Singh M, Howe J, et al. Observations on the ultrastructure and viability of the cystic stage of Blastocystis hominis from human feces. Parasitol Res 1996; 82:439.
  20. Ok UZ, Girginkardeşler N, Balcioğlu C, et al. Effect of trimethoprim-sulfamethaxazole in Blastocystis hominis infection. Am J Gastroenterol 1999; 94:3245.
  21. Wong KH, Ng GC, Lin RT, et al. Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore. Parasitol Res 2008; 102:663.
  22. Stensvold CR, Alfellani MA, Nørskov-Lauritsen S, et al. Subtype distribution of Blastocystis isolates from synanthropic and zoo animals and identification of a new subtype. Int J Parasitol 2009; 39:473.
  23. Scanlan PD, Stensvold CR, Cotter PD. Development and Application of a Blastocystis Subtype-Specific PCR Assay Reveals that Mixed-Subtype Infections Are Common in a Healthy Human Population. Appl Environ Microbiol 2015; 81:4071.
  24. Zierdt CH. Pathogenicity of Blastocystis hominis. J Clin Microbiol 1991; 29:662.
  25. Zierdt CH. Blastocystis hominis--past and future. Clin Microbiol Rev 1991; 4:61.
  26. Blastocystis hominis as a human pathogen. Rev Infect Dis 1989; 11:661.
  27. Qadri SM, al-Okaili GA, al-Dayel F. Clinical significance of Blastocystis hominis. J Clin Microbiol 1989; 27:2407.
  28. Markell EK, Udkow MP. Blastocystis hominis: pathogen or fellow traveler? Am J Trop Med Hyg 1986; 35:1023.
  29. Sun T, Katz S, Tanenbaum B, Schenone C. Questionable clinical significance of Blastocystis hominis infection. Am J Gastroenterol 1989; 84:1543.
  30. Chen TL, Chan CC, Chen HP, et al. Clinical characteristics and endoscopic findings associated with Blastocystis hominis in healthy adults. Am J Trop Med Hyg 2003; 69:213.
  31. Scanlan PD, Stensvold CR, Rajilić-Stojanović M, et al. The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. FEMS Microbiol Ecol 2014; 90:326.
  32. Clark CG. Extensive genetic diversity in Blastocystis hominis. Mol Biochem Parasitol 1997; 87:79.
  33. Yoshikawa H, Nagano I, Wu Z, et al. Genomic polymorphism among Blastocystis hominis strains and development of subtype-specific diagnostic primers. Mol Cell Probes 1998; 12:153.
  34. Kukoschke KG, Müller HE. SDS-PAGE and immunological analysis of different axenic Blastocystis hominis strains. J Med Microbiol 1991; 35:35.
  35. Boreham PF, Upcroft JA, Dunn LA. Protein and DNA evidence for two demes of Blastocystis hominis from humans. Int J Parasitol 1992; 22:49.
  36. Elwakil HS, Talaat RM. Genetic analysis of Blastocystis hominis isolated from symptomatic and asymptomatic human hosts in Egypt. J Egypt Soc Parasitol 2009; 39:99.
  37. Souppart L, Sanciu G, Cian A, et al. Molecular epidemiology of human Blastocystis isolates in France. Parasitol Res 2009; 105:413.
  38. Tan TC, Suresh KG, Smith HV. Phenotypic and genotypic characterisation of Blastocystis hominis isolates implicates subtype 3 as a subtype with pathogenic potential. Parasitol Res 2008; 104:85.
  39. Vennila GD, Suresh Kumar G, Khairul Anuar A, et al. Irregular shedding of Blastocystis hominis. Parasitol Res 1999; 85:162.
  40. Keystone JS. Blastocystis hominis and traveler's diarrhea. Clin Infect Dis 1995; 21:102.
  41. Grossman I, Weiss LM, Simon D, et al. Blastocystis hominis in hospital employees. Am J Gastroenterol 1992; 87:729.
  42. Markell EK. Is there any reason to continue treating Blastocystis infections? Clin Infect Dis 1995; 21:104.
  43. Nourrisson C, Scanzi J, Pereira B, et al. Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS One 2014; 9:e111868.
  44. Cirioni O, Giacometti A, Drenaggi D, et al. Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts. Eur J Epidemiol 1999; 15:389.
  45. Albrecht H, Stellbrink HJ, Koperski K, Greten H. Blastocystis hominis in human immunodeficiency virus-related diarrhea. Scand J Gastroenterol 1995; 30:909.
  46. Ok UZ, Cirit M, Uner A, et al. Cryptosporidiosis and blastocystosis in renal transplant recipients. Nephron 1997; 75:171.
  47. Zuckerman MJ, Watts MT, Ho H, Meriano FV. Blastocystis hominis infection and intestinal injury. Am J Med Sci 1994; 308:96.
  48. Llibre JM, Tor J, Manterola JM, et al. Blastocystis hominis chronic diarrhoea in AIDS patients. Lancet 1989; 1:221.
  49. Garavelli PL, Orsi P, Scaglione L. Blastocystis hominis infection during AIDS. Lancet 1988; 2:1364.
  50. Hussain R, Jaferi W, Zuberi S, et al. Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome. Am J Trop Med Hyg 1997; 56:301.
  51. Giacometti A, Cirioni O, Fiorentini A, et al. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 1999; 18:436.
  52. Yakoob J, Jafri W, Jafri N, et al. Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg 2004; 70:383.
  53. Tungtrongchitr A, Manatsathit S, Kositchaiwat C, et al. Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health 2004; 35:705.
  54. Stensvold CR, Lewis HC, Hammerum AM, et al. Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. Epidemiol Infect 2009; 137:1655.
  55. Yakoob J, Jafri W, Beg MA, et al. Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 2010; 107:679.
  56. Hameed DM, Hassanin OM, Zuel-Fakkar NM. Association of Blastocystis hominis genetic subtypes with urticaria. Parasitol Res 2011; 108:553.
  57. Casero RD, Mongi F, Sánchez A, Ramírez JD. Blastocystis and urticaria: Examination of subtypes and morphotypes in an unusual clinical manifestation. Acta Trop 2015; 148:156.
  58. Lee MG, Rawlins SC, Didier M, DeCeulaer K. Infective arthritis due to Blastocystis hominis. Ann Rheum Dis 1990; 49:192.
  59. Patino WD, Cavuoti D, Banerjee SK, et al. Cytologic diagnosis of blastocystis hominis in peritoneal fluid: a case report. Acta Cytol 2008; 52:718.
  60. Fréalle E, El Safadi D, Cian A, et al. Acute blastocystis-associated appendicular peritonitis in a child, Casablanca, Morocco. Emerg Infect Dis 2015; 21:91.
  61. Horiki N, Maruyama M, Fujita Y, et al. Epidemiologic survey of Blastocystis hominis infection in Japan. Am J Trop Med Hyg 1997; 56:370.
  62. Zuckerman MJ, Ho H, Hooper L, et al. Frequency of recovery of Blastocystis hominis in clinical practice. J Clin Gastroenterol 1990; 12:525.
  63. Suresh K, Smith H. Comparison of methods for detecting Blastocystis hominis. Eur J Clin Microbiol Infect Dis 2004; 23:509.
  64. Nigro L, Larocca L, Massarelli L, et al. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 2003; 10:128.
  65. Zierdt CH, Zierdt WS, Nagy B. Enzyme-linked immunosorbent assay for detection of serum antibody to Blastocystis hominis in symptomatic infections. J Parasitol 1995; 81:127.
  66. Jones MS 2nd, Ganac RD, Hiser G, et al. Detection of Blastocystis from stool samples using real-time PCR. Parasitol Res 2008; 103:551.
  67. Roberts T, Barratt J, Harkness J, et al. Comparison of microscopy, culture, and conventional polymerase chain reaction for detection of blastocystis sp. in clinical stool samples. Am J Trop Med Hyg 2011; 84:308.
  68. Wolfe MS. The treatment of intestinal protozoan infections. Med Clin North Am 1982; 66:707.
  69. Zaman V, Zaki M. Resistance of Blastocystis hominis cysts to metronidazole. Trop Med Int Health 1996; 1:677.
  70. Haresh K, Suresh K, Khairul Anus A, Saminathan S. Isolate resistance of Blastocystis hominis to metronidazole. Trop Med Int Health 1999; 4:274.
  71. Roberts T, Ellis J, Harkness J, et al. Treatment failure in patients with chronic Blastocystis infection. J Med Microbiol 2014; 63:252.
  72. Armentia A, Méndez J, Gómez A, et al. Urticaria by Blastocystis hominis. Successful treatment with paromomycin. Allergol Immunopathol (Madr) 1993; 21:149.
  73. van Hellemond JJ, Molhoek N, Koelewijn R, et al. Is paromomycin the drug of choice for eradication of Blastocystis in adults? J Infect Chemother 2013; 19:545.
  74. Rossignol JF, Kabil SM, Said M, et al. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol 2005; 3:987.